Kadmon Holdings, Inc.

Kadmon Holdings, Inc.: May 30 PDUFA data for belumosudil (cGVHD) following positive primary analysis results (May 2020); observed ORRs of 73% and 74% in 200mg QD and 200mg BID arms, respectively. Initiating 12-15 pt open-label Ph 2 in patients w diffuse cutaneous systemic sclerosis in Q1 2021. First 3-pt dose cohort successfully completed in ongoing dose-escalation Ph 1 (anti-PD-L1/IL-15 fusion protein) in patients w metastatic or locally advanced solid tumors; enrollment ongoing in next dose level. Continuing IND-enabling activities of KD045, Kadmon's next-gen ROCK inhibitor for treatment of fibrotic diseases.
Based in...
US - Middle Atlantic
Clinical Stage
Phase III
Disease Space
Autoimmune, Fibrosis, Immunotherapy, Oncology
Biotechnology, Pharmaceuticals
Public, USA
Market Cap
500MM - 1B
450 East 29th Street
New York, NY 10016
United States

Company Participants at Solebury Trout CEO & Investor Ski Conference 2020

  • Ellen Cavaleri, Investor Relations
  • Harlan W. Waksal, MD, President/CEO
  • Steve Meehan, CFO

Lead Programs


Indication Phase
Chronic Graft-Versus-Host Disease 2
Systemic Sclerosis 2
Idiopathic Pulmonary Fibrosis 2


Indication Phase
Wilson’s Disease 3

Top 10 Holders of Kadmon Holdings Inc Warrant 2017-28.09.22 On Kadmon Hldngs

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
The Vanguard Group, Inc. 0.00 0 0.00 Funds 10/31/20
Sofinnova Ventures, Inc. 0.00 0 0.00 13F 9/30/20

Top 10 Holders of Kadmon Holdings, Inc.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Perceptive Advisors LLC 9.84 15,711,334 75.73 13F 9/30/20
Consonance Capital Management LP 8.78 14,007,548 67.52 13F 9/30/20
Point72 Asset Management LP 5.67 9,049,800 43.62 Stakes 1/13/21
Avidity Partners Management LP 5.66 9,030,000 43.52 13F 9/30/20
The Vanguard Group, Inc. 5.59 8,922,790 43.01 Funds 12/31/20
State Street Corp. 5.41 8,635,710 41.62 13F 9/30/20
Vanguard Group, Inc. (Subfiler) 5.25 8,385,658 40.42 13F 9/30/20
Third Point LLC 4.76 7,601,115 36.64 13F 9/30/20
Citadel LP 4.13 6,587,531 31.75 13F 9/30/20
Boxer Capital LLC 3.89 6,205,882 29.91 13F 9/30/20
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.